MedTrace Logo

Epigenetic and Neurochemical Correlates of Bipolar Disorder

NCT06829316 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2025-02-17

No results posted yet for this study

Summary

Aim of Study:

* To assess DNA methylation of the IL1-B gene in individuals with BD compared to healthy controls.
* To evaluate the expression of 5-hydroxytryptamine (serotonin) receptors in BD and shed more light into its role into the pathophysioogy of BD.
* To measure differences of glutamic acid levels between study groups.
* To investigate correlations between these biomarkers among study groups, and their alignment with clinical presentations.

Conditions

  • Bipolar Disorder (BD)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Months
Max Age
45 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-03-30
Completion
2026-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06829316 on ClinicalTrials.gov